QuantLogix ← LH scorecard
📅 LH Earnings Preview
Labcorp Holdings Inc.
Next report (est.)
11/28/2026
Countdown
81 days
EPS growth YoY
+28.2%
Revenue growth YoY
+5.8%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/05/2026 ±3.8% +0.5% over-priced
05/04/2026 ±3.2% -1.1% over-priced
10/31/2025 ±4.5% +0.7% over-priced
08/01/2025 ±2.3% +0.6% over-priced
04/29/2025 ±2.5% +4.7% under-priced
10/29/2024 ±4.1% +0.3% over-priced
08/02/2024 ±3.2% +1.1% over-priced
04/30/2024 ±3.4% -1.4% over-priced
Across these reports, options implied an average ±3.4% move vs an actual average of 1.3% — the stock stayed inside the implied band 88% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $3.64 $3.7B $299M
Q1 FY2026 $3.35 $3.5B $278M
Q4 FY2025 $1.98 $3.5B $165M
Q3 FY2025 $3.12 $3.6B $262M
Analyst posture
Buy / Strong Buy
21
Hold
6
Sell
0
Stable: +0 net change 30d
Live 5-factor engine read: Strong Buy · 59/100 Full scorecard →
Get alerted before every LH report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on LH before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Labcorp Holdings Inc. (LH) reports in 81 days, with the next report estimated for 11/28/2026. Across the last 8 reports, options priced an average ±3.4% earnings move while the stock actually moved 1.3% on average — the market has systematically over-priced LH's earnings risk. Fundamentals into the print: EPS up 28.2% year-over-year, revenue up 5.8%. QuantLogix's live 5-factor engine currently reads LH as a strong buy at 59/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →